- Home
- Publications
- Publication Search
- Publication Details
Title
Receptor tyrosine kinases and their activation in melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 24, Issue 3, Pages 446-461
Publisher
Wiley
Online
2011-02-15
DOI
10.1111/j.1755-148x.2011.00836.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platelet-Derived Growth Factor-Receptor α Strongly Inhibits Melanoma Growth In Vitro and In Vivo
- (2015) Debora Faraone et al. NEOPLASIA
- The protein tyrosine phosphatase receptor D, a broadly inactivated tumor suppressor regulating STAT function
- (2011) Timothy A. Chan et al. CELL CYCLE
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
- (2010) D Handolias et al. BRITISH JOURNAL OF CANCER
- EphA2 as a promoter of melanoma tumorigenicity
- (2010) Naira V. Margaryan et al. CANCER BIOLOGY & THERAPY
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
- (2010) Qing-Bai She et al. CANCER CELL
- Receptor Tyrosine Kinase Coactivation Networks in Cancer
- (2010) A. M. Xu et al. CANCER RESEARCH
- IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
- (2010) Lyndee L. Scurr et al. CELL
- Role for IGFBP7 in Senescence Induction by BRAF
- (2010) Narendra Wajapeyee et al. CELL
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response
- (2010) C. A. Pratilas et al. CLINICAL CANCER RESEARCH
- Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: A new potential therapy for the treatment of melanoma
- (2010) Thomas B. Karasic et al. EXPERIMENTAL CELL RESEARCH
- Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
- (2010) M. D. Schaller JOURNAL OF CELL SCIENCE
- Novel Hinge Binder Improves Activity and Pharmacokinetic Properties of BRAF Inhibitors
- (2010) Alfonso Zambon et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Current Status and Evolving Role of Sunitinib in Non-small Cell Lung Cancer
- (2010) Mark A. Socinski Journal of Thoracic Oncology
- Tie1-Tie2 Interactions Mediate Functional Differences between Angiopoietin Ligands
- (2010) Tom C.M. Seegar et al. MOLECULAR CELL
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation
- (2010) P J Mishra et al. ONCOGENE
- Nuclear trafficking of the epidermal growth factor receptor family membrane proteins
- (2010) Y-N Wang et al. ONCOGENE
- PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
- (2010) Ruth Halaban et al. Pigment Cell & Melanoma Research
- EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility Style
- (2009) M. Parri et al. CANCER RESEARCH
- Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma
- (2009) N. Schicher et al. CLINICAL CANCER RESEARCH
- Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
- (2009) S.-C. Wang et al. CLINICAL CANCER RESEARCH
- Tyrosine phosphorylation: thirty years and counting
- (2009) Tony Hunter CURRENT OPINION IN CELL BIOLOGY
- Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
- (2009) Janice M. Mehnert et al. HUMAN PATHOLOGY
- Ultraviolet irradiation-induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes
- (2009) Yiru Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- KIT as a Therapeutic Target in Melanoma
- (2009) Maria C. Garrido et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
- (2009) Emelie A. Djerf et al. MELANOMA RESEARCH
- Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
- (2009) Michael G. Gartside et al. MOLECULAR CANCER RESEARCH
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
- (2009) Todd D Prickett et al. NATURE GENETICS
- ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma
- (2009) Aline Primot et al. Pigment Cell & Melanoma Research
- A genomic screen identifies TYRO3 as a MITF regulator in melanoma
- (2009) S. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
- (2009) C. A. Pratilas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II trial of imatinib mesylate in patients with metastatic melanoma
- (2008) K B Kim et al. BRITISH JOURNAL OF CANCER
- Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression
- (2008) K. S.M. Smalley et al. CANCER RESEARCH
- EphA2 Is an Essential Mediator of UV Radiation-Induced Apoptosis
- (2008) G. Zhang et al. CANCER RESEARCH
- Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
- (2008) D. A. Solomon et al. CANCER RESEARCH
- Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor-Negative Melanoma Cells
- (2008) J. Goodall et al. CANCER RESEARCH
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7
- (2008) Narendra Wajapeyee et al. CELL
- Eph-Ephrin Bidirectional Signaling in Physiology and Disease
- (2008) Elena B. Pasquale CELL
- PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic β-catenin and affects membrane distribution of β-catenin/E-cadherin complexes in cancer cells
- (2008) Luisa Novellino et al. CELLULAR SIGNALLING
- HER3 Is a Determinant for Poor Prognosis in Melanoma
- (2008) M. Reschke et al. CLINICAL CANCER RESEARCH
- A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
- (2008) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma
- (2008) X. Jiang et al. CLINICAL CANCER RESEARCH
- Acquired resistance to tyrosine kinase inhibitors during cancer therapy
- (2008) Jeffrey A Engelman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Meeting Report: Receptor tyrosine kinases: the emerging tip of systems control
- (2008) R. Seger et al. IET Systems Biology
- Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas
- (2008) Atsuko Ashida et al. INTERNATIONAL JOURNAL OF CANCER
- Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase
- (2008) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Metastatic Melanoma: Scientific Rationale for Sorafenib Treatment and Clinical Results
- (2008) Friederike Egberts et al. ONKOLOGIE
- Understanding Signaling Cascades in Melanoma
- (2008) Pablo Lopez-Bergami et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
- (2008) Jose Lutzky et al. Pigment Cell & Melanoma Research
- Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib
- (2008) Alfonso Quintás-Cardama et al. Nature clinical practice. Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started